BioSpace News Archive

Evox Therapeutics Ltd, a leading exosome therapeutics company, is pleased to announce the appointment of Martin Andrews as a Non-Executive Director.

An early age of pregnancy is known to reduce the overall risk of breast cancer by over 30%. CSHL Assistant Professor Camila dos Santos spent several years teasing out the molecular details behind the protective effects of pregnancy.

CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced financial results for the first quarter ended March 31, 2020 and provided an update on the Company’s business developments. Certain metrics, including those expressed on an adjusted basis, are non-GAAP measures. See “Use of Non-GAAP Measures”

Sierra Oncology, Inc. announced that Dr. Barbara Klencke, Chief Development Officer, will present the company at the upcoming Jefferies Global Virtual Healthcare Conference and at the Oppenheimer Biotech by the Lake 2020 Investor Summit.

ESSA Pharma Inc., a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer announced the Company will be presenting at the Jefferies Virtual Healthcare Conference on Thursday June 4, 2020 at 3:30pm Eastern.

Spectrum Pharmaceuticals, a biopharmaceutical company focused on novel and targeted oncology therapies, announced that management will present an overview of the company’s business strategy and development-stage programs at the Jefferies Virtual Healthcare Conference 2020.

Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in fireside chats at the following virtual investor conferences in June:

Zeposia offers relapsing remitting multiple sclerosis (RRMS) patients with active disease in the European Union a new oral option to help address the disease’s hallmark relapses and brain lesions

Deciphera Pharmaceuticals, Inc., a commercial biopharmaceutical company addressing key mechanisms of tumor drug resistance, announced that Steve Hoerter, President and Chief Executive Officer, will present at the Jefferies 2020 Healthcare Conference on Wednesday, June 3, 2020 at 2:00 PM ET.

Clinical Data Offer Meaningful Diagnostic Information for Patients in the Lung Cancer Continuum of Care